Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by BearDownAZon Mar 11, 2016 9:27am
203 Views
Post# 24647365

RE:T-RVX ... Then & Now

RE:T-RVX ... Then & NowA couple of refinements.

Daily high on 4/27/15 was $3.00, but closed at $2.87. 4/27/15 was the day of the Hepalink announcement, as you indicated.

In general from 4/16/15 to 4/27/15 the share price kept rising. And in general April was a huge month for high volume trading with several days in the above 500K traded per day.

Prior to the Hepalink announcement on 4/27/15 was the Richmond Club presentation on 4/22/15. On this day, the price rose to as high as $2.96 and closed at $2.80.

2016 Roth Conference coming up March 13-16, 2016.
2016 Richmond Club coming up March 23rd, 2016.

BearDownAZ
Bullboard Posts